1 – 2 of 2
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2003
 - 
                        Mark
        Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
    
    
- Contribution to journal › Article
 
 - 2002
 - 
                        Mark
        Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
    
    
- Contribution to journal › Article